LC, LC-MS/TOF and MSn studies for the identification and characterization of degradation products of nelfinavir mesylate

Journal of Pharmaceutical and Biomedical Analysis

Volumn 55, Issue 3, 2011, Pages 435-445

  Tiwari, Ravi N ^a   Bonde, Chandrakant G ^a  

^a School of Pharmacy and Technology Management   (India)

Author keywords

Degradation pathway; LC; LC MS TOF; MSn; Nelfinavir mesylate; Stress studies

Indexed keywords

NELFINAVIR;

ACIDITY; ARTICLE; DRUG DECOMPOSITION; DRUG DEGRADATION; DRUG IDENTIFICATION; FRAGMENTATION REACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; LIQUID CHROMATOGRAPHY; OXIDATION; PHOTOLYSIS; PRIORITY JOURNAL; SEPARATION TECHNIQUE; TEMPERATURE STRESS; TIME OF FLIGHT MASS SPECTROMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; GUIDELINES AS TOPIC; HIV PROTEASE INHIBITORS; HYDROLYSIS; MASS SPECTROMETRY; MODELS, CHEMICAL; MOLECULAR STRUCTURE; NELFINAVIR; OXIDATION-REDUCTION; PHOTOLYSIS; REPRODUCIBILITY OF RESULTS; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE;

EID: 79953173201     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.02.020     Document Type: Article

References (23)

1. Patick A., Hong M., Markowitz D., Ho D., Webber S. Proceedings of the 2nd National Conference on Retroviruses and Related Infections 1995, vol. 184:88. (Abstract).
2. Hugen P.W.H., Verweij-van Wissen C.P.W.G.M., Burger D.M., Wuis E.W., Koopmans P.P., Hekster Y.A. Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography. J. Chromatogr. B 1999, 727:139-149.
3. Aymard G., Legrand M., Trichereau N., Diquet B. Determination of twelve antiretroviral agents in human plasma sample using reversed-phase high-performance liquid chromatography. J. Chromatogr. B 2000, 744:227-240.
4. Lamotte C., Peytavin G., Farinotti R. Determination of nelfinavir, a potent HIV protease inhibitor, and its active metabolite M8 in human plasma by high-performance liquid chromatography with photodiode-array detection. J. Chromatogr. B 1999, 735:159-170.
5. Wu E.Y., Wilkinson J.M., Naret D.G., Daniels V.L., Williams L.J., Khalil D.A., Shetty B.V. High-performance liquid chromatographic method for the determination of nelfinavir, a novel HIV-1 protease inhibitor in human plasma. J. Chromatogr. B 1997, 695:373-380.
6. Jing Q., Shen Y., Tang Y., Ren F., Yu X., Hou Z. Determination of nelfinavir mesylate as bulk drug and in pharmaceutical dosage form by stability indicating HPLC. J. Pharm. Biomed. Anal. 2006, 41:1065-1069.
7. Seshachalam U., Rajababu B., Haribabu B., Chandrasekhar K.B. Novel stability - indicating RP-LC method for the determination of nelfinavir mesylate and its related impurities in drug substance and pharmaceutical formulations. J. Liq. Chromatogr. Relat. Technol. 2008, 31:395-409.
8. Kaul N., Agrawal H., Paradkar A.R., Mahadik K.R. Stability indicating high performance thin-layer chromatographic determination of nelfinavir mesylate as bulk drug and in pharmaceutical dosage form. Anal. Chim. Acta. 2004, 502:31-38.
9. Yamada H., Kotaki H., Nakamura T., Iwamoto A. Simultaneous determination of HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir and nelfinavir in human plasma by high-performance liquid chromatography. J. Chromatogr. B 2001, 755:85-89.
10. Marzolini C., Telenti A., Buclin T., Biollaz J. Simultaneous determination of the HIV. protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non- nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid phase extraction. J. Chromatogr. B 2000, 740:43-58.
11. Turner M.L., Reed-Walker K., King J.R., Acosta E.P. Simultaneous determination of nine antiretroviral compounds in human plasma using liquid chromatography. J. Chromatogr. B 2003, 784:331-341.
12. Dailly E., Thomas L., Kergueris M.F., Jolliet P., Bourin M. High-performance liquid chromatographic assay to determine the plasma levels of HIV protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction. J. Chromatogr. B 2001, 758:129-135.
13. Sarasa-Nacenta M., Lopez-Pua Y., Mallolas J., Blanco J.L. Simultaneous. determination of HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reverse-phase high-performance liquid chromatography. J. Chromatogr. B 2001, 757:325-332.
14. Justesen U.S., Pedersen C., Klitgaard N.A. Simultaneous quantitative determination of the HIV protease inhibitors indinavir, amprenavir, ritonavir, lopinavir, saquinavir and the nelfinavir active metabolite M8 in plasma by liquid chromatography. J Chromatogr. B 2003, 783:491-500.
15. Janoly A., Bleyzac N., Favetta P., Gagneu M.C. Simple and rapid high-performance liquid chromatographic method for nelfinavir, M8 nelfinavir metabolite, ritonavir and saquinavir assay in plasma. J. Chromatogr. B 2002, 780:155-160.
16. van Heeswijk R.P.G., Hoetelmans R.M.W., Harms R., Meenhorst P.L. Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high performance liquid chromatography with ultraviolet detection. J. Chromatogr. B 1998, 719:159-168.
17. Rentsch K.M. Sensitive and specific determination of eight antiretroviral agents in plasma by high-performance liquid chromatography-mass spectrometry. J. Chromatogr. B 2003, 788:339-350.
18. Chi J., Jayewardene A.L., Stone J.A., Motoya T. Simultaneous determination of five HIV protease inhibitors nelfinavir, indinavir, ritonavir, saquinavir and amprenavir in human plasma by LC/MS/MS. J. Pharm. Biomed. Anal. 2002, 30:675-684.
19. I.C.H. Stability testing of new drug substances and products Q1A(R2). International Conference on Harmonisation 2003, IFMPA, Geneva.
20. W.H.O. Draft Stability Testing of Active Pharmaceutical Ingredients and Pharmaceutical Products 2007, World Health Organization, Geneva.
21. I.C.H. Stability testing: Photostability Testing of New Drug Substances and Products Q1B 1996, International Conference on Harmonisation, IFPMA, Geneva.
22. Singh S., Bakshi M. Guidance on conduct of stress tests to determine inherent stability of drugs. Pharm. Technol. 2000, 24:1-14. On-line.
23. I.C.H. Validation of Analytical Procedures: Text and Methodology, Q2(R1) 2005, International Conference on Harmonization IFPMA, Geneva.